Goldman Sachs sells 3.80 lakh shares of Strides Arcolab

07 Dec 2013 Evaluate

Goldman Sachs Investments Mauritius has sold around 3.80 lakh shares of Strides Arcolab in an open market transaction. The foreign fund house has sold a total of 380,748 shares at an average price of Rs 876.84 a piece valuing the transaction to Rs 33.38 crore.

As on quarter ending September 2013, Goldman Sachs Investments Mauritius held 33.91 lakh shares of Strides Arcolab representing 5.73% stake in the company.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

Strides Pharma Scien Share Price

878.65 -7.00 (-0.79%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×